As age increases, weakened eyesight—especially nearsightedness (presbyopia)—becomes almost inevitable. Millions worldwide suffer from this condition, which makes reading or focusing on nearby objects difficult, often forcing people to rely on reading glasses.
Presbyopia typically begins after the age of 40, when the natural lens of the eye loses flexibility, making it hard to adjust focus for close-up tasks. While distant objects remain clear, reading or detailed work becomes challenging.
Now, a breakthrough from Argentina brings new hope. Scientists there have developed innovative eye drops that could eliminate the need for glasses altogether. These drops combine two compounds—pilocarpine and diclofenac—to temporarily restore near vision.
According to a report by SciTech Daily, the new formulation targets the symptoms of presbyopia rather than curing the condition itself. The drops work by constricting the pupils to create a “pinhole effect,” improving the eye’s depth of focus and allowing clearer vision for nearby objects.
Experts explain that current treatments for presbyopia are limited and often come with complications, but these new drops offer a safer, longer-lasting, and non-surgical alternative.
If approved for widespread use, this innovation could transform the daily lives of millions—turning just two drops a day into a simple solution for age-related vision loss.
